RxDoctor Payments Data

Robert Benson, MD

Family Medicine · Statesboro, GANPI 1013921428

Payments from drug & device makers

$5,841in general payments, 2019–2025

Across 340 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$846
  • AstraZeneca$801
  • Amgen$573
  • AbbVie$572
  • Lilly USA, LLC$315
  • Boehringer Ingelheim$220
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$5,841100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,841 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$59,276
Medicare patients
157
Services billed
690

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide117$123,380
Diclofenac Sodium26$54,864
JardianceEmpagliflozin69$48,752
MounjaroTirzepatide42$43,648
TrulicityDulaglutide37$41,713
EliquisApixaban20$15,589
AbrysvoRsv Vacc, Pref A And Pref B/Pf46$13,979
MresviaRsv Vaccine, Pref, Mrna/Pf41$12,011
ShingrixVaricella-Zoster Ge/As01b/Pf55$11,440
Metformin Er GastricMetformin Hcl15$7,013
Colesevelam Hcl16$5,580
Dexlansoprazole DrDexlansoprazole13$4,627
ArexvyRsvpref3 Antigen/As01e/Pf14$4,000
Naproxen28$3,344
Levothyroxine Sodium259$3,136

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$846$123,380117 claims
Lilly USA, LLCMounjaro, Trulicity$315$85,36279 claims
Boehringer IngelheimJardiance$220$48,75269 claims
PfizerEliquis, Abrysvo$200$29,56866 claims
GSKShingrix, Arexvy$155$15,44069 claims
AbbVieSynthroid$572$1,52622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Statesboro

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →